GROUP ONE TRADING, L.P. - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 68 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$0
-100.0%
11
-100.0%
0.00%
Q2 2020$24,000
-44.2%
31,436
-25.7%
0.00%
Q1 2020$43,000
-68.8%
42,336
-52.6%
0.00%
-100.0%
Q4 2019$138,000
-17.9%
89,313
-4.0%
0.00%0.0%
Q3 2019$168,000
+136.6%
93,040
+113.6%
0.00%0.0%
Q2 2019$71,000
+91.9%
43,567
+108.5%
0.00%
Q1 2019$37,000
+1750.0%
20,900
+2017.5%
0.00%
Q2 2018$2,0009870.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,484,714$2,658,0002.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 549,750$984,0000.14%
BARD ASSOCIATES INC 88,184$158,0000.08%
EAM Investors, LLC 160,628$288,0000.07%
Regal Investment Advisors LLC 193,450$346,0000.07%
HighTower Advisors, LLC 5,284,838$9,460,0000.06%
HIGHLAND CAPITAL MANAGEMENT LP 545,000$976,0000.06%
Granite Point Capital Management, L.P. 329,000$589,0000.06%
Kore Private Wealth LLC 104,366$187,0000.04%
Verition Fund Management LLC 498,167$892,0000.04%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders